Case Report

Published on 05 Aug 2024

Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review

in Hematologic Malignancies

Mengyuan Liu
Kexing Ren
Ping Ai
Liqun Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1419145

811 views
1 citation

Review

Published on 02 Aug 2024

MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response

in Hematologic Malignancies

Ilina Dimitrova Micheva
Svilena Angelova Atanasova

Frontiers in Oncology

doi 10.3389/fonc.2024.1410656

912 views

Case Report

Published on 01 Aug 2024

Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review

in Hematologic Malignancies

Jianchao Wang
Wensheng Liao
Zhongwen Liu
Dai Kong

Frontiers in Oncology

doi 10.3389/fonc.2024.1417380

860 views

Case Report

Published on 31 Jul 2024

Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence

in Hematologic Malignancies

Nicolò Peccatori
Elena Chiocca
Valentino Conter
Annalisa Tondo
Matilde Marzorati
Tommaso Casini
Marinella Veltroni
Andrea Biondi
Grazia Fazio

Frontiers in Oncology

doi 10.3389/fonc.2024.1457832

966 views

Systematic Review

Published on 31 Jul 2024

Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data

in Hematologic Malignancies

Tong Yoon Kim
Tae Jung Kim
Eun Ji Han
Gi June Min
Youngwoo Jeon
Seok-Goo Cho

Frontiers in Oncology

doi 10.3389/fonc.2024.1362367

795 views

Systematic Review

Published on 31 Jul 2024

Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

in Hematologic Malignancies

Si Yu Lin
Ke Jie Lu
Xiao Na Zheng
Jian Hou
Ting Ting Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1341631

791 views

Review

Published on 29 Jul 2024

Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy

in Hematologic Malignancies

Binsah George
Kok Hoe Chan
Adan Rios

Frontiers in Oncology

doi 10.3389/fonc.2024.1446517

1,530 views

Original Research

Published on 29 Jul 2024

Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma

in Hematologic Malignancies

Mayur Narkhede
Sarah Tomassetti
Madiha Iqbal
Antony Tin
Samuel Rivero-Hinojosa
Giby V. George
Hayley Widden
Ryan Benrud
Meenakshi Malhotra
Angel Rodriguez

Frontiers in Oncology

doi 10.3389/fonc.2024.1407003

1,280 views

Review

Published on 29 Jul 2024

Novel insights and therapeutic approaches in secondary AML

in Hematologic Malignancies

Giovanni Marconi
Michela Rondoni
Beatrice Anna Zannetti
Irene Zacheo
Davide Nappi
Agnese Mattei
Serena Rocchi
Francesco Lanza

Frontiers in Oncology

doi 10.3389/fonc.2024.1400461

1,675 views

Review

Published on 26 Jul 2024

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms

in Hematologic Malignancies

Luca L. G. Janssen
Nathalie van Leeuwen-Kerkhoff
Theresia M. Westers
Tanja D. de Gruijl
Arjan A. van de Loosdrecht

Frontiers in Oncology

doi 10.3389/fonc.2024.1414102

1,037 views

Review

Published on 24 Jul 2024

Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives

in Hematologic Malignancies

Massimo Breccia
Francesca Palandri
Nicola Polverelli
Morena Caira
Michela Berluti
Giuseppe A. Palumbo
Valerio De Stefano

Frontiers in Oncology

doi 10.3389/fonc.2024.1382872

2,300 views

Original Research

Published on 19 Jul 2024

Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia

in Hematologic Malignancies

Xiaohong Wang
Jason Ostergaard
Jongseok Kang
Grace Sagong
Rachel Twite
Andrea Vargas-Morales
Peter M. Gordon

Frontiers in Oncology

doi 10.3389/fonc.2024.1440650

940 views

Review

Published on 19 Jul 2024

Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma

in Hematologic Malignancies

Fernando J. Medina-Olivares
Andrés Gómez-De León
Nilanjan Ghosh

Frontiers in Oncology

doi 10.3389/fonc.2024.1397613

1,748 views
1 citation

Mini Review

Published on 18 Jul 2024

Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas

in Hematologic Malignancies

Domenico Ribatti
Gerardo Cazzato
Roberto Tamma
Tiziana Annese
Giuseppe Ingravallo
Giorgina Specchia

Frontiers in Oncology

doi 10.3389/fonc.2024.1420920

1,410 views

Systematic Review

Published on 18 Jul 2024

A systematic review and meta-analysis on utilizing anti-CD19 chimeric antigen receptor T-cell therapy as a second-line treatment for relapsed and refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Kanwal Asghar
Maryam Zafar
Eva Holland
Ali Bin Abduljabbar
Sara A. Albagoush
Noureen Asghar
Akshat Sood
Jalal M. Dufani
Joseph Thirumalaredy
Bradley DeVrieze

Frontiers in Oncology

doi 10.3389/fonc.2024.1407001

1,359 views

Case Report

Published on 18 Jul 2024

Familial 46, XY Disorder of Sexual Development identified in a Ph+BCR::ABL1P210+ Acute Lymphoblastic Leukemia septuagenarian female with RCBTB2::LPAR6 fusion gene: a case report

in Hematologic Malignancies

Lingling Wang
Conglin Xi
Xinyu Zheng
Yongfen Huang
Hao Xu
Yuqing Miao
Yuexin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2024.1339737

744 views

Navigation group

Articles

Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review

MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response

Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review

Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence

Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data

Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy

Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma

Novel insights and therapeutic approaches in secondary AML

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms

Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives

Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia

Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma

Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas

A systematic review and meta-analysis on utilizing anti-CD19 chimeric antigen receptor T-cell therapy as a second-line treatment for relapsed and refractory diffuse large B-cell lymphoma

Familial 46, XY Disorder of Sexual Development identified in a Ph+BCR::ABL1P210+ Acute Lymphoblastic Leukemia septuagenarian female with RCBTB2::LPAR6 fusion gene: a case report